Arjan W Griffioen

Articles in Scholarly Journals [Incomplete List]

  1. Dual targeting of epigenetic therapy in cancer
    Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol. 1775, no. 1, pp. 76–91, 2007
  2. Molecular pathways of angiogenesis inhibition
    Biochemical and Biophysical Research Communications, vol. 355, no. 1, pp. 1–5, 2007
  3. Intrinsic pro-angiogenic status of cystic fibrosis airway epithelial cells???
    Biochemical and Biophysical Research Communications, vol. 356, no. 3, pp. 745–749, 2007
  4. Targeted gene-delivery strategies for angiostatic cancer treatment
    Trends in Molecular Medicine, vol. 13, no. 5, pp. 200–209, 2007
  5. Therapeutic Approaches of Angiogenesis Inhibition: Are We Tackling the Problem at the Right Level?
    Trends in Cardiovascular Medicine, vol. 17, no. 5, pp. 171–176, 2007
  6. High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT–PCR mRNA expression profile
    British Journal of Cancer, vol. 96, no. 12, Article ID 6603796, 7 pages, 2007
  7. Early in vivo assessment of angiostatic therapy efficacy by molecular MRI
    The FASEB Journal, vol. 21, no. 2, pp. 378–383, 2007
  8. Identification of Epigenetically Silenced Genes in Tumor Endothelial Cells
    Cancer Research, vol. 67, no. 9, pp. 4138–4148, 2007
  9. Magnetic and fluorescent nanoparticles for multimodality imaging
    Nanomedicine, vol. 2, no. 3, pp. 307–324, 2007
  10. Epigenetic Regulation of Tumor Endothelial Cell Anergy: Silencing of Intercellular Adhesion Molecule-1 by Histone Modifications
    Cancer Research, vol. 66, no. 22, pp. 10770–10777, 2006
  11. Angiostatic activity of DNA methyltransferase inhibitors
    Molecular Cancer Therapeutics, vol. 5, no. 2, pp. 467–475, 2006
  12. Gene expression of tumor angiogenesis dissected: specific targeting of colon cancer angiogenic vasculature
    Blood, vol. 108, no. 7, pp. 2339–2348, 2006
  13. Monocyte/macrophage infiltration in tumors: modulators of angiogenesis
    Journal of Leukocyte Biology, vol. 80, no. 6, pp. 1183–1196, 2006
  14. Proliferating endothelial cells, but not microvessel density, are a prognostic parameter in human cutaneous melanoma
    Melanoma Research, vol. 16, no. 5, pp. 453–457, 2006
  15. Design of Nonpeptidic Topomimetics of Antiangiogenic Proteins With Antitumor Activities
    CancerSpectrum Knowledge Environment, vol. 98, no. 13, pp. 932–936, 2006
  16. Expression and regulation of vascular endothelial growth factor ligands and receptors during menstruation and post-menstrual repair of human endometrium
    Molecular Human Reproduction, vol. 12, no. 6, pp. 367–375, 2006
  17. Anti-angiogenesis therapy can overcome endothelial cell anergy and promote leukocyte-endothelium interactions and infiltration in tumors
    The FASEB Journal, vol. 20, no. 6, pp. 621–630, 2006
  18. Nano Letters, vol. 6, no. 1, pp. 1–6, 2006
  19. Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy
    Proceedings of the National Academy of Sciences, vol. 103, no. 43, pp. 15975–15980, 2006
  20. Anti-angiogenesis and anti-tumor activity of recombinant anginex?
    Biochemical and Biophysical Research Communications, vol. 349, no. 3, pp. 1073–1078, 2006
  21. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis
    Cancer Cell, vol. 10, no. 5, pp. 437–449, 2006
  22. Proliferating Endothelial Cells and Leukocyte Infiltration as Prognostic Markers in Colorectal Cancer
    Clinical Gastroenterology and Hepatology, vol. 4, no. 11, pp. 1351–1357, 2006
  23. Effects of radiotherapy and chemotherapy on angiogenesis and leukocyte infiltration in rectal cancer
    International Journal of Radiation OncologyBiologyPhysics, vol. 66, no. 4, pp. 1219–1227, 2006
  24. Towards high-throughput functional target discovery in angiogenesis research
    Trends in Molecular Medicine, vol. 12, no. 1, pp. 44–52, 2006
  25. Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging
    NMR in Biomedicine, vol. 19, no. 1, pp. 142–164, 2006
  26. Evaluation of Gd(III)DTPA-terminated poly(propylene imine) dendrimers as contrast agents for MR imaging
    NMR in Biomedicine, vol. 19, no. 1, pp. 133–141, 2006
  27. Cloning an artificial gene encoding angiostatic anginex: From designed peptide to functional recombinant protein
    Biochemical and Biophysical Research Communications, vol. 333, no. 4, pp. 1261–1268, 2005
  28. Anginex synergizes with radiation therapy to inhibit tumor growth by radiosensitizing endothelial cells
    International Journal of Cancer, vol. 115, no. 2, pp. 312–319, 2005
  29. In silico analysis of angiogenesis associated gene expression identifies angiogenic stage related profiles
    Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol. 1755, no. 2, pp. 121–134, 2005
  30. Editorial
    Angiogenesis, vol. 8, no. 1, pp. 1–1, 2005
  31. Angiostatic agents prevent the development of endometriosis-like lesions in the chicken chorioallantoic membrane
    Fertility and Sterility, vol. 83, no. 3, pp. 793–795, 2005
  32. Dynamic contrast-enhanced magnetic resonance imaging of radiation therapy-induced microcirculation changes in rectal cancer
    International Journal of Radiation Oncology*Biology*Physics, vol. 63, no. 5, pp. 1309–1315, 2005
  33. Dynamic Contrast-enhanced MR Imaging Kinetic Parameters and Molecular Weight of Dendritic Contrast Agents in Tumor Angiogenesis in Mice
    Radiology, vol. 235, no. 1, pp. 65–72, 2005
  34. Tumor Cell Plasticity in Ewing Sarcoma, an Alternative Circulatory System Stimulated by Hypoxia
    Cancer Research, vol. 65, no. 24, pp. 11520–11528, 2005
  35. MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle
    The FASEB Journal, 2005
  36. Antiangiogenesis Therapy for Endometriosis
    Journal of Clinical Endocrinology & Metabolism, vol. 89, no. 3, pp. 1089–1095, 2004
  37. Angiogenic Profile of Breast Carcinoma Determines Leukocyte Infiltration
    Clinical Cancer Research, vol. 10, no. 21, pp. 7171–7178, 2004
  38. Platelet Factor 4 and Interleukin-8 CXC Chemokine Heterodimer Formation Modulates Function at the Quaternary Structural Level
    Journal of Biological Chemistry, vol. 280, no. 6, pp. 4948–4958, 2004
  39. Effects of Angiogenesis Inhibitors on Vascular Network Formation by Human Endothelial and Melanoma Cells
    CancerSpectrum Knowledge Environment, vol. 96, no. 19, pp. 1473–1477, 2004
  40. Dynamic contrast-enhanced magnetic resonance imaging at 1.5 Tesla with gadopentetate dimeglumine to assess the angiostatic effects of anginex in mice
    European Journal of Cancer, vol. 40, no. 8, pp. 1262–1268, 2004
  41. Bioconjugate Chemistry, vol. 15, no. 4, pp. 799–806, 2004
  42. HIV-1 Tat increases the adhesion of monocytes and T-cells to the endothelium in vitro and in vivo: implications for AIDS-associated vasculopathy*1
    Virus Research, vol. 104, no. 2, pp. 145–155, 2004
  43. Angiogenesis gene expression profiling in xenograft models to study cellular interactions
    Experimental Cell Research, vol. 299, no. 2, pp. 286–293, 2004
  44. Anti-tumor activity of the novel angiogenesis inhibitor anginex
    Cancer Letters, vol. 194, no. 1, pp. 55–66, 2003
  45. Vascular targeting effect of combretastatin A-4 phosphate dominates the inherent angiogenesis inhibitory activity
    International Journal of Cancer, vol. 105, no. 1, pp. 20–25, 2003
  46. Design of a Partial Peptide Mimetic of Anginex with Antiangiogenic and Anticancer Activity
    Journal of Biological Chemistry, vol. 278, no. 46, pp. 45746–45752, 2003
  47. Discovery and development of anti-angiogenic peptides: A structural link
    Angiogenesis, vol. 6, no. 2, pp. 83–91, 2003
  48. Eur?conference Angiogenesis II
    Angiogenesis, vol. 6, no. 3, pp. 159–164, 2003
  49. ß-Sheet is the bioactive conformation of the anti-angiogenic anginex peptide
    Biochemical Journal, vol. 373, no. 1, p. 281, 2003
  50. Designing betapep peptides: A rational approach to the discovery of novel pharmaceutical agents and small molecules
    Drugs of the Future, vol. 28, no. 4, p. 337, 2003
  51. Gadopentetate Dimeglumine versus Ultrasmall Superparamagnetic Iron Oxide for Dynamic Contrast-enhanced MR Imaging of Tumor Angiogenesis in Human Colon Carcinoma in Mice
    Radiology, vol. 229, no. 2, pp. 429–438, 2003
  52. Flow cytometric quantification of tumour endothelial cells; an objective alternative for microvessel density assessment
    British Journal of Cancer, vol. 87, no. 3, pp. 344–347, 2002
  53. The antiangiogenic properties of bactericidal/permeability-increasing protein (BPI)
    Annals of Medicine, vol. 34, no. 1, pp. 19–27, 2002
  54. Angiogenesis, vol. 4, no. 1, pp. 45–51, 2001
  55. Anginex, a designed peptide that inhibits angiogenesis
    Biochemical Journal, vol. 354, no. 2, p. 233, 2001
  56. Tumor angiogenesis factors reduce leukocyte adhesion in vivo
    International Immunology, vol. 12, no. 5, pp. 671–676, 2000
  57. Quantitative Assessment of Angiogenesis and Tumor Vessel Architecture by Computer-Assisted Digital Image Analysis: Effects of VEGF–Toxin Conjugate on Tumor Microvessel Density
    Microvascular Research, vol. 59, no. 3, pp. 368–376, 2000
  58. Angiogenesis inhibitors overcome tumor induced endothelial cell anergy
    International Journal of Cancer, vol. 80, no. 2, pp. 315–319, 1999
  59. Angiogenesis, a target for tumor therapy
    Journal of Laboratory and Clinical Medicine, vol. 132, no. 5, pp. 363–368, 1998
  60. Effect of culture conditions on endothelial cell growth and responsiveness
    Tissue and Cell, vol. 30, no. 5, pp. 525–530, 1998
  61. Rocking the foundations of solid tumor growth by attacking the tumor's blood supply
    Immunology Today, vol. 19, no. 9, pp. 392–394, 1998
  62. Angiogenesis modulates the tumour immune response
    International Journal of Experimental Pathology, vol. 79, no. 6, pp. 363–368, 1998
  63. Angiogenesis, vol. 2, no. 3, pp. 235–243, 1998
  64. In vitro Tumor Angiogenesis Assays: Plasminogen Lysine Binding Site 1 Inhibits in vitro Tumor-Induced Angiogenesis
    Journal of Vascular Research, vol. 35, no. 2, pp. 109–114, 1998
  65. Endothelial CD34 is suppressed in human malignancies: role of angiogenic factors
    Cancer Letters, vol. 120, no. 2, pp. 203–211, 1997
  66. Endoglin/CD 105 may not be an optimal tumor endothelial treatment target
    Breast Cancer Research and Treatment, vol. 39, no. 2, pp. 239–240, 1996
  67. Signaling through CD44 Is Mediated by Tyrosine Kinases
    Journal of Biological Chemistry, vol. 271, no. 5, pp. 2863–2867, 1996
  68. Expression and Functional Characteristics of the Complement Receptor Type 2 on Adult and Neonatal B Lymphocytes
    Clinical Immunology and Immunopathology, vol. 69, no. 1, pp. 1–8, 1993
  69. CD44 splice variants; expression on lymphocytes and in neoplasia
    Research in Immunology, vol. 144, no. 9, pp. 750–754, 1993
  70. Role of CR2 in the human adult and neonatal antibody response to type 4 pneumococcal polysaccharide
    Cellular Immunology, vol. 143, no. 1, pp. 11–22, 1992
  71. T cell function in patients with impaired antibody responses to polysaccharide antigens
    European Journal of Immunology, vol. 21, no. 9, pp. 2293–2296, 1991
  72. The Human in Vitro Anti-type 4 Pneumococcal Polysaccharide Antibody Response is Regulated by Suppressor T Cells
    Scandinavian Journal of Immunology, vol. 34, no. 2, pp. 229–236, 1991
  73. Ligation of Membrane Immunoglobulin Leads to Inactivation of the Signal- Transducing Ability of Membrane Immunoglobulin, CD19, CD21, and B-Cell gp95
    Proceedings of the National Academy of Sciences, vol. 87, no. 22, pp. 8766–8770, 1990
  74. INCA: Software for consort 30 analysis of flow cytometric calcium determinations
    Cytometry, vol. 10, no. 6, pp. 814–817, 1989
  75. Measurement of cytoplasmic calcium in lymphocytes using flow cytometry Kinetic studies and single cell analysis
    Journal of Immunological Methods, vol. 120, no. 1, pp. 23–27, 1989
  76. Entorhinal projections to the hippocampal CA1 region in the rat: An underestimated pathway
    Neuroscience Letters, vol. 85, no. 2, pp. 193–198, 1988